JP2023506488A5 - - Google Patents

Info

Publication number
JP2023506488A5
JP2023506488A5 JP2022535707A JP2022535707A JP2023506488A5 JP 2023506488 A5 JP2023506488 A5 JP 2023506488A5 JP 2022535707 A JP2022535707 A JP 2022535707A JP 2022535707 A JP2022535707 A JP 2022535707A JP 2023506488 A5 JP2023506488 A5 JP 2023506488A5
Authority
JP
Japan
Prior art keywords
methyl
pyrimidine
chloro
amine
aminopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022535707A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023506488A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/063612 external-priority patent/WO2021118929A1/en
Publication of JP2023506488A publication Critical patent/JP2023506488A/ja
Publication of JP2023506488A5 publication Critical patent/JP2023506488A5/ja
Priority to JP2025097641A priority Critical patent/JP2025133750A/ja
Pending legal-status Critical Current

Links

JP2022535707A 2019-12-12 2020-12-07 家族性自律神経失調症を処置するための化合物 Pending JP2023506488A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025097641A JP2025133750A (ja) 2019-12-12 2025-06-11 家族性自律神経失調症を処置するための化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962947049P 2019-12-12 2019-12-12
US62/947,049 2019-12-12
PCT/US2020/063612 WO2021118929A1 (en) 2019-12-12 2020-12-07 Compounds for treating familial dysautonomia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025097641A Division JP2025133750A (ja) 2019-12-12 2025-06-11 家族性自律神経失調症を処置するための化合物

Publications (2)

Publication Number Publication Date
JP2023506488A JP2023506488A (ja) 2023-02-16
JP2023506488A5 true JP2023506488A5 (https=) 2023-12-15

Family

ID=74046197

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022535707A Pending JP2023506488A (ja) 2019-12-12 2020-12-07 家族性自律神経失調症を処置するための化合物
JP2025097641A Pending JP2025133750A (ja) 2019-12-12 2025-06-11 家族性自律神経失調症を処置するための化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025097641A Pending JP2025133750A (ja) 2019-12-12 2025-06-11 家族性自律神経失調症を処置するための化合物

Country Status (14)

Country Link
US (1) US20230057568A1 (https=)
EP (1) EP4072677A1 (https=)
JP (2) JP2023506488A (https=)
KR (1) KR20220113700A (https=)
CN (1) CN115209955A (https=)
AU (1) AU2020402717A1 (https=)
BR (1) BR112022011364A2 (https=)
CA (1) CA3160053A1 (https=)
CL (1) CL2022001523A1 (https=)
CO (1) CO2022008195A2 (https=)
IL (1) IL293764A (https=)
MX (1) MX2022007094A (https=)
PE (1) PE20221581A1 (https=)
WO (1) WO2021118929A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202108519TA (en) 2019-02-13 2021-09-29 Ptc Therapeutics Inc Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia
WO2020167624A1 (en) 2019-02-13 2020-08-20 Ptc Therapeutics, Inc. Pyrrolo[2,3-d]pyrimidine compounds for treating familial dysautonomia
MX2024002887A (es) * 2021-09-07 2024-05-28 Ptc Therapeutics Inc Metodos para tratar enfermedades neurodegenerativas.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1028964A1 (en) * 1997-11-11 2000-08-23 Pfizer Products Inc. Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
WO2005007083A2 (en) * 2003-06-18 2005-01-27 Smithkline Beecham Corporation Chemical compounds
JP2009007341A (ja) * 2007-06-01 2009-01-15 Mitsubishi Tanabe Pharma Corp 医薬組成物
EP2014663A1 (de) * 2007-07-12 2009-01-14 Bayer Schering Pharma AG Thienopyrimidylamine als Modulatoren des EP2-Rezeptors
EP2611812A1 (en) * 2010-09-01 2013-07-10 Ambit Biosciences Corporation Thienopyridine and thienopyrimidine compounds and methods of use thereof
CN103242341B (zh) * 2013-04-19 2015-12-09 中国科学院广州生物医药与健康研究院 噻吩并2，4取代嘧啶类化合物及其药物组合物与应用
CA2973949C (en) * 2015-01-16 2023-07-11 The General Hospital Corporation Compounds for improving mrna splicing
GB201700814D0 (en) * 2017-01-17 2017-03-01 Liverpool School Tropical Medicine Compounds
WO2018151326A1 (ja) * 2017-02-20 2018-08-23 国立大学法人京都大学 スプライシング異常に起因する遺伝性疾病のための医薬組成物及び治療方法
SG11202108519TA (en) * 2019-02-13 2021-09-29 Ptc Therapeutics Inc Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia
WO2020167624A1 (en) * 2019-02-13 2020-08-20 Ptc Therapeutics, Inc. Pyrrolo[2,3-d]pyrimidine compounds for treating familial dysautonomia

Similar Documents

Publication Publication Date Title
JP2023506488A5 (https=)
JP2022520822A5 (https=)
IL317705A (en) Compounds for the treatment of spinocerebellar ataxia type 3
JP2024540445A5 (https=)
JP2021515033A5 (https=)
AU2015304851A1 (en) Heterocyclic amides as RIP1 kinase inhibitors as medicaments
JP2016523963A5 (https=)
JP2003525872A5 (https=)
JP2016510035A5 (https=)
JP2019504901A5 (https=)
JP2021535134A5 (https=)
SI2961736T1 (en) Histone demethylase inhibitors
CA2610888A1 (en) Inhibitors of akt activity
RU2013108702A (ru) Ингибиторы деметилазы lsd1 на основе арилциклопропиламина и их применение в медицине
RU2013112744A (ru) Алкил 2-{[(2r,3s,5r)-5-(4-амино-2-оксо-2н-пиримидин-1-ил)-гидрокси-тетрагидро-фуран-2-илметокси]-фенокси-фосфориламино}-пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения
ME01507B (me) Imidazotriazini i imidazopirimidini kao inhibitori kinaze
JP2019507179A5 (https=)
JP2010533158A5 (https=)
RU2348628C2 (ru) Замещенные циклопропильной группой оксазолидиноновые антибиотики и их производные
RU2013143028A (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
JP2008516986A5 (https=)
RU2017121044A (ru) Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы
JP2010534673A (ja) 抗細菌性アミド及びスルホンアミド置換複素環式尿素化合物
JP2024533264A5 (https=)
JP2015505542A5 (https=)